Medical devices, healthcare technology and the business of care
510(k) clearance · K260337

SEEG-Tx System (STX-SYS-001)

Dixi Medical · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONK260337

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the SEEG-Tx® System (STX-SYS-001), submitted by Dixi Medical of Marchaux-Chaudefontaine, France, under 510(k) number K260337. The decision date is 2026-10-29; the application was received 02/02/2026. The device falls under regulation 882.4400 with classification product code GXD and subsequent product code GXI, and the regulation medical specialty and 510k review panel are both listed as Neurology. A 510(k) SESE decision is a clearance, not a PMA approval.

The record identifies the device classification name as Generator, Lesion, Radiofrequency and the submission type as Traditional, with no third-party review, no combination product status and no authorized Predetermined Change Control Plan. The correspondent is Medtech Regulatory Strategist, Inc. The source does not describe the device's components, the specific changed item, indications for use, or the predicate device, so those details remain unknown here and would need the linked summary document.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Oct 29, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260337
Regulatory pathway
510(k) premarket notification
Applicant
Dixi Medical
Product code
GXD
Decision code
SESE
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Generator, Lesion, Radiofrequency.

Applicant
Dixi Medical
Product code
GXD
FDA device class
2

FDA decision timeline

  1. K260337 received

    Application receipt date recorded by FDA.

  2. K260337 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Dixi Medical

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Marchaux-Chaudefontaine

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records